Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | UBS | TJX |
|---|---|---|
| Price | $47.83 | $131.43 |
| Change today | ▲ 0.18% | ▼ 0.12% |
| Market cap | $146.43B | $144.57B |
| Return, 3 months | -3.2% | -20.2% |
| Return, year to date | +6.0% | -13.6% |
| Return, 1 year | +18.2% | -5.3% |
| P/E (TTM) | 16.3 | 24.3 |
| P/B | 1.6 | 13.6 |
| P/E percentile vs own 5y | 65th | 9th |
| Dividend yield | 2.30% | 1.34% |
| Revenue growth (YoY, latest qtr) | +15.9% | +5.4% |
| Net profit growth (YoY) | +17.0% | +22.3% |
| Gross margin | – | 32.0% |
| Operating margin | – | 12.7% |
| Net margin | 18.7% | 9.7% |
| Return on equity | 10.7% | 62.2% |
| Analyst target vs. price | +20.3% | +31.4% |
| Analyst buy share | 63% | 82% |
| RSI (14) | 27 | 44 |
| 30-day volatility | 22.6% | 24.3% |
| Max drawdown, 1 year | -26.1% | -26.8% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.